News Experts criticise new German law for favouring drug companies BMJ 2010; 341 doi: https://doi.org/10.1136/bmj.c5650 (Published 13 October 2010) Cite this as: BMJ 2010;341:c5650 Article Related content Metrics Responses Peer review Related articles Analysis Finding studies on reboxetine: a tale of hide and seek Published: 12 October 2010; BMJ 341 doi:10.1136/bmj.c4942 See more Stroke care: Can triage technologies reverse stalled progress? BMJ March 11, 2025, 388 r500; DOI: https://doi.org/10.1136/bmj.r500 Stroke: New NHS campaign urges people to call 999 as soon as symptoms show BMJ November 04, 2024, 387 q2435; DOI: https://doi.org/10.1136/bmj.q2435 Stroke: Take test for genetic variant to ensure clopidogrel works for prevention, says NICE BMJ May 19, 2023, 381 p1146; DOI: https://doi.org/10.1136/bmj.p1146 David Oliver: What the plan for social care omitted BMJ September 10, 2021, 374 n2227; DOI: https://doi.org/10.1136/bmj.n2227 Stroke: “striking reductions” are seen in number of people with symptoms seeking help BMJ April 06, 2020, 369 m1406; DOI: https://doi.org/10.1136/bmj.m1406
